drugset / Trial / NCT00775671

Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome

NCT00775671

Phase 4 Completed 46 enrolled Vanderbilt University
RandomizedParallel-groupQuadruple-blindBasic science

Summary

Test the hypothesis that nebivolol treatment improves fibrinolytic balance and insulin sensitivity compared to metoprolol treatment in individuals with metabolic syndrome.

Timeline

Start
2008-10
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metoprolol Other / unclassified 100 mg Oral
Comparator Nebivolol Other / unclassified 5 mg Oral

Indications